114 related articles for article (PubMed ID: 35012841)
1. Serial monitoring of ionised calcium levels in plateletpheresis donors: A study from tertiary care oncology centre in India.
Navkudkar A; Desai P; Rajadhyaksha S
Transfus Apher Sci; 2022 Jun; 61(3):103350. PubMed ID: 35012841
[TBL] [Abstract][Full Text] [Related]
2. The Play of Citrate Infusion with Calcium in Plateletpheresis Donors.
Lokhande T; Thomas S; Kumar G; Bajpai M
Indian J Hematol Blood Transfus; 2021 Apr; 37(2):295-301. PubMed ID: 33867737
[TBL] [Abstract][Full Text] [Related]
3. Alteration in biochemical parameters during plateletpheresis in healthy donors: A compendious analysis.
Garg K; Kaur P; Bedi RK; Gupta S
Transfus Clin Biol; 2021 Aug; 28(3):239-245. PubMed ID: 33965622
[TBL] [Abstract][Full Text] [Related]
4. Calcium and magnesium levels during automated plateletpheresis in normal donors.
Das SS; Chaudhary R; Khetan D; Shukla JS; Agarwal P; Mishra RB
Transfus Med; 2005 Jun; 15(3):233-6. PubMed ID: 15943708
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of changes in clinically significant divalent serum cation levels during automated plateletpheresis in healthy donors in a tertiary care center in North India.
Solanki A; Agarwal P
Asian J Transfus Sci; 2015; 9(2):124-8. PubMed ID: 26420928
[TBL] [Abstract][Full Text] [Related]
6. Frequency of adverse events in plateletpheresis donors in regional transfusion centre in North India.
Patidar GK; Sharma RR; Marwaha N
Transfus Apher Sci; 2013 Oct; 49(2):244-8. PubMed ID: 23830186
[TBL] [Abstract][Full Text] [Related]
7. Hypocalcemic symptoms during plateletpheresis using the COBE Spectra: a comparison of oral combination of 600mg calcium+300mg magnesium+100IU vitamin D3 vs. a 1000mg calcium in symptomatic donors.
Palfi M; Martinsson L; Sundström K
Transfus Apher Sci; 2007 Jun; 36(3):291-5. PubMed ID: 17613274
[TBL] [Abstract][Full Text] [Related]
8. Clinical and clinicopathologic effects of plateletpheresis on healthy donor dogs.
Callan MB; Appleman EH; Shofer FS; Mason NJ; Brainard BM; Groman RP
Transfusion; 2008 Oct; 48(10):2214-21. PubMed ID: 18564392
[TBL] [Abstract][Full Text] [Related]
9. Randomized placebo-controlled study of oral calcium carbonate administration in plateletpheresis: I. Associations with donor symptoms.
Bolan CD; Wesley RA; Yau YY; Cecco SA; Starling J; Oblitas JM; Rehak NN; Leitman SF
Transfusion; 2003 Oct; 43(10):1403-13. PubMed ID: 14507272
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic administration of oral calcium carbonate during plateletpheresis: A bicentric prospective study.
Pandey PK; Tiwari A; Agarwal N; Dara RC
Asian J Transfus Sci; 2020; 14(1):19-22. PubMed ID: 33162700
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of citrate effects during plateletpheresis in normal donors.
Bolan CD; Greer SE; Cecco SA; Oblitas JM; Rehak NN; Leitman SF
Transfusion; 2001 Sep; 41(9):1165-71. PubMed ID: 11552076
[TBL] [Abstract][Full Text] [Related]
12. Plateletpheresis donation through donor awareness, motivation, and recruitment drives: A unique concept and experience from a tertiary care oncology centre in India.
Ojha S; Gupta AM; Nagaraju P; Poojary M; Ravatale A
Transfus Clin Biol; 2022 Feb; 29(1):65-69. PubMed ID: 34302952
[TBL] [Abstract][Full Text] [Related]
13. Assessment of pre and post donation changes in hematological parameters and serum calcium and magnesium levels in plateletpheresis donors.
Syal N; Kukar N; Arora H; Kaur A; Handa A; Maharishi RN
J Family Med Prim Care; 2022 Apr; 11(4):1489-1492. PubMed ID: 35516708
[TBL] [Abstract][Full Text] [Related]
14. Importance of ionized magnesium measurement for monitoring of citrate-anticoagulated plateletpheresis.
Mercan D; Bastin G; Lambermont M; Dupont E
Transfusion; 1997 Apr; 37(4):418-22. PubMed ID: 9111280
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of automated plateletpheresis using five different apheresis systems in a tertiary care hospital.
Chaudhary R; Das SS; Khetan D; Ojha S; Verma S
Transfus Apher Sci; 2009 Apr; 40(2):99-103. PubMed ID: 19237317
[TBL] [Abstract][Full Text] [Related]
16. Randomized placebo-controlled study of oral calcium carbonate supplementation in plateletpheresis: II. Metabolic effects.
Bolan CD; Cecco SA; Yau YY; Wesley RA; Oblitas JM; Rehak NN; Leitman SF
Transfusion; 2003 Oct; 43(10):1414-22. PubMed ID: 14507273
[TBL] [Abstract][Full Text] [Related]
17. Plateletpheresis with the IBM model 2997. I. Effects of ACD, NIH formula B on selected donor indices.
Mishler JM; Lund P; Borberg H
Vox Sang; 1980; 38(1):36-9. PubMed ID: 7376565
[TBL] [Abstract][Full Text] [Related]
18. A liquid calcium+vitamin D
Weinstein R; Haynes S; Zhao Y; Hickson E; Linden J; St Pierre P; Ducharme P; Sulmasy P; Graves M; Bailey JA; Welch L; Simard A; Vauthrin M; Greene M
J Clin Apher; 2018 Feb; 33(1):60-64. PubMed ID: 28653765
[TBL] [Abstract][Full Text] [Related]
19. Comparison of plateletpheresis using two cell separators and identical donors.
Bertholf MF; Mintz PD
Transfusion; 1989; 29(6):521-3. PubMed ID: 2749875
[TBL] [Abstract][Full Text] [Related]
20. Laboratory and clinical effects of the infusion of ACD solution during plateletpheresis.
Olson PR; Cox C; McCullough J
Vox Sang; 1977 Aug; 33(2):79-87. PubMed ID: 883248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
